These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4420897)

  • 21. Evaluation of oral methotrexate in the treatment of systemic sclerosis.
    Krishna Sumanth M; Sharma VK; Khaitan BK; Kapoor A; Tejasvi T
    Int J Dermatol; 2007 Feb; 46(2):218-23. PubMed ID: 17269983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of methotrexate in pediatric dermatology].
    Mazereeuw-Hautier J; Uthurriague C
    Ann Dermatol Venereol; 2016 Feb; 143(2):154-61. PubMed ID: 26724843
    [No Abstract]   [Full Text] [Related]  

  • 23. [Delagil treatment of urocoproporphyria].
    Idel'son LI
    Klin Med (Mosk); 1980 May; 58(5):61-3. PubMed ID: 6770170
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug survival and reasons for discontinuation of intramuscular methotrexate: a study of 212 consecutive patients switching from oral methotrexate.
    Linde L; Hetland ML; Ostergaard M
    Scand J Rheumatol; 2006; 35(2):102-6. PubMed ID: 16641042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of methotrexate in the treatment of pemphigus (5 cases)].
    Grupper MC; Bourgeois-Spinasse J; Durepaire R
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):380-4. PubMed ID: 5510731
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of skin disorders with intramuscular triamcinolone acetonide.
    Rosten M
    N Z Med J; 1970 Oct; 72(461):253-5. PubMed ID: 5275018
    [No Abstract]   [Full Text] [Related]  

  • 27. [Oral therapy of psoriasis using methotrexate].
    Janula J
    Cesk Dermatol; 1974 Apr; 49(2):123-8. PubMed ID: 4828205
    [No Abstract]   [Full Text] [Related]  

  • 28. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
    Carpentier N; Bertin P; Marquet P; Sabot C; Bonnet C; Debord J; Lachâtre G; Trèves R
    J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of chronic refractory skin diseases with synthetic ACTH, Cortrocin-depot].
    Hayakawa M
    Hifuka Kiyo; 1970 Feb; 65(1):51-61. PubMed ID: 4321317
    [No Abstract]   [Full Text] [Related]  

  • 30. [Our experience with methotrexate in psoriasis].
    Beurey J; Weber M; Hort P; Souris D
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):404-6. PubMed ID: 5510735
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of multicentric reticulohistiocytosis with a combination of infliximab, prednisolone and methotrexate.
    Lee MW; Lee EY; Jeong YI; Choi JH; Moon KC; Koh JK
    Acta Derm Venereol; 2004; 84(6):478-9. PubMed ID: 15844643
    [No Abstract]   [Full Text] [Related]  

  • 32. [Globulin anomalies in skin mucinosis].
    Degos R; Civatte J; Clauvel JP; Danon F
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(5):579-91. PubMed ID: 5518184
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
    Dadlani C; Orlow SJ
    J Am Acad Dermatol; 2005 Feb; 52(2):316-40. PubMed ID: 15692480
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-biochemical parallels in the treatment of psoriasis with small doses of methotrexate].
    Nikulin NK
    Vestn Dermatol Venerol; 1974 Oct; 0(10):70-4. PubMed ID: 4432620
    [No Abstract]   [Full Text] [Related]  

  • 35. An injectable corticoid for resistant dermatoses.
    Lincoln CS; Nordstrom RC
    West Med Med J West; 1966 Jul; 7(7):196-8. PubMed ID: 6013702
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood absorption by the skin in patients treated with methotrexate and imuran].
    Kozlowski J; Szyszymar B
    Przegl Dermatol; 1974; 61(5):607-12. PubMed ID: 4422714
    [No Abstract]   [Full Text] [Related]  

  • 37. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Action of oral mesoglycan in dermatology].
    Scarsella A; Legge A; Di Stanislao C; Scarsella S
    G Ital Dermatol Venereol; 1988 Jun; 123(6):XXIX-XXXII. PubMed ID: 2975270
    [No Abstract]   [Full Text] [Related]  

  • 39. [Personal experience with methotrexate in the treatment of various bullous diseases (Duhring-Brocq, pemphigus)].
    Basset A; Bergoend H; Grosshans E; Heid E; Maleville J
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):371-6. PubMed ID: 5510728
    [No Abstract]   [Full Text] [Related]  

  • 40. [The treatment of some resistant dermatoses with pyrogenal].
    Fel'ker AIa
    Vestn Dermatol Venerol; 1973 Jan; 47(1):81-3. PubMed ID: 4709902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.